Neuralink has announced the launch of a study aimed at testing technology that allows paralyzed individuals to control a robotic arm. This initiative represents a significant advancement for Elon Musk's company.
The start-up, founded in 2016 by Elon Musk and several engineers, is developing a brain-computer interface to enable individuals with limited mobility to control a computer, prosthesis, or smartphone using their thoughts. The initial implant, the N1, is currently being tested on two quadriplegic patients in the United States, and the company recently received approval from Canada to conduct a clinical trial on one of its citizens.
Neuralink is now seeking to expand its capabilities. In a post on X.com, the company announced the approval and launch of a new feasibility trial aimed at extending the brain-computer interface control using the N1 implant to an experimental assistive robotic arm. This early-stage study, named Convoy, may take years before a device receives regulatory approval. Neuralink views this as a crucial step toward restoring not only digital freedom but also physical independence.
